BTAI vs U · rev $2.3M vs rev $1.85B
BioXcel Therapeutics Inc (BTAI) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Unity Software Inc (U) is a software - application company listed on US.
Latest reported BTAI revenue for 2024-12-31 was $2.3M. Net income was -$59.6M. Revenue was up 64.2% from 2023-12-31 to 2024-12-31. BTAI currently screens at market cap $36.1M.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
BTAI currently screens at market cap $36.1M. U currently screens at market cap $16.98B.
Not investment advice. Open the BTAI and U stock pages for the full models.
Not investment advice.